Pharmacological management of cancer pain: Novel therapeutics


Celina G.Virgen, Neil Kelkar, Aaron Tran, Christina M. Rosa, Diana Cruz-Topete, Shripa Amatya, Elyse M.Cornett, Ivan Urits, Omar Viswanath, Alan David Kaye


December 2022


Patients diagnosed with cancer often experience pain during their treatment course, making it difficult to care for themselves and continue with their activities of daily living. When cancer is found at later stages, the pain can become severe and constant; reducing their quality of life and significantly affecting mental and physical well-being. Despite opioids being known to provide adequate analgesia for higher pain levels, they are often the reason for under-dosing because of their adverse effects and concern for addiction. There are also patients who do not respond well to opioids because of genetic anomalies or personal preference. Therefore, there is a need for novel non-opioid cancer pain treatments. There are many new cancer pain treatments that are emerging. This manuscript discusses cancer pain, risk factors, epidemiology, guidelines for the treatment of cancer pain, personalization of cancer pain therapy, breakthrough pain, cancer-induced peripheral neuropathy, established cancer pain treatment options, and novel emerging cancer pain treatment options.


DOI: 10.1016/j.biopha.2022.113871


Virgen, C. G., Kelkar, N., Tran, A., Rosa, C. M., Cruz-Topete, D., Amatya, S., … & Kaye, A. D. (2022). Pharmacological management of cancer pain: Novel therapeutics. Biomedicine & Pharmacotherapy, 156, 113871.